MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer von Parikh, Aparna R, Lee, Fa-Chyi, Yau, Linda, Koh, Han, Knost, James, Mitchell, Edith P, Bosanac, Ivan, Choong, Nicholas, Scappaticci, Frank, Mancao, Christoph, Lenz, Heinz-Josef

Volltext

Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer von Shah, Manish A, Wainberg, Zev A, Catenacci, Daniel V T, Hochster, Howard S, Ford, James, Kunz, Pamela, Lee, Fa-Chyi, Kallender, Howard, Cecchi, Fabiola, Rabe, Daniel C, Keer, Harold, Martin, Anne-Marie, Liu, Yuan, Gagnon, Robert, Bonate, Peter, Liu, Li, Gilmer, Tona, Bottaro, Donald P

Volltext

Case Report: A complete pathologic response in pancreatic cancer with squamous cell differentiation von Grant, Christopher R, Arter, Zhaohui L, Truc, Tran, Lee, Fa-Chyi

Volltext

A case report of challenges in distinguishing gastroesophageal junction hepatoid adenocarcinoma from testicular germ cell tumor: Insights for improved diagnosis with gene expressio... von Yazdanpanah, Omid, Lee, Fa-Chyi, Houshyar, Roozbeh, Nourbakhsh, Mahra, Mar, Nataliya

Volltext

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study von Qin, Shukui, Chan, Stephen L, Bai, Yuxian, Chen, Zhendong, Jia, Weidong, Jin, Yongdong, Guo, Yabing, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Chen, Yajin, Zeng, Yong, Sultanbaev, Alexander, Pazgan-Simon, Monika, Melisi, Davide, Ponomarenko, Dmitriy, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Wang, Linna, Cheng, Ann-Lii, Vogel, Arndt, Qin, Shukui, Chan, Stephen L, Vogel, Arndt, Gu, Shanzhi, Bai, Yuxian, Ren, Zhenggang, Lin, Xiaoyan, Chen, Zhendong, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Yang, Fang, Zeng, Yong, Sultanbaev, Alexander, Pisetska, Margaryta, Melisi, Davide, Ponomarenko, Dmitriy, Osypchuk, Yurii, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Zhang, Mingxiang, Xu, Li, Li, Da, Ying, Jierer, Zhang, Jingdong, Zhang, Tao, He, Yifu, Jiang, Da, Xing, Baocai, Zhang, Baihong, Wang, Dong, Zhai, Xiaofeng, Liang, Houjie, Cybulska-Stopa, Bozena, Dvorkin, Mikhail, Stroyakovskiy, Daniil, Yen, Chia-Jui, Su, Wei-Wen, Chen, Yen-Hao, Bondarenko, Igor, Fang, Weijia, Gomez-Martin, Carlos, Ryu, Min-Hee, Kim, Han-Sang, Kim, Jee-Hyun, Orlova, Rashida, Fadeeva, Natalia, Makarova, Yulia, Hung, Chao-Hung, Neffa, Maryna, Vynnychenko, Oleksandr, Burgoyne, Adam, Hao, Chunyi, Mohr, Raphael U, Diaz-Beveridge, Roberto, Feliu-Batlle, Jaime, Antonuzzo, Lorenzo, Scartozzi, Mario, Ahn, Mi Sun, Oh, Sung-Yong, Orlov, Sergey, Oksuzoglu, Berna, Rau, Kun-Ming, Krechkovskyi, Oleksandr, Yareshko, Vladimir, Xiong, Henry, Lee, Fa-Chyi, Jiang, Yixing, Verset, Gontran

Volltext

Longterm clinical remission of oral and cutaneous pemphigus with thalidomide von Lee, Fa‐Chyi

Volltext

Medical oncology management of advanced hepatocellular carcinoma 2019: a reality check von Lee, Amy, Lee, Fa-Chyi

Volltext

Multicenter Phase II Trial of S-1 Plus Cisplatin in Patients With Untreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma von AJANI, Jaffer A, LEE, Fa-Chyi, SINGH, Deepti A, HALLER, Daniel G, LENZ, Heinz-Josef, BENSON, Al B, YANAGIHARA, Ronald, PHAN, Alexandria T, YAO, James C, STRUMBERG, Dirk

Volltext

Extended safety and efficacy data on S‐1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study von Lenz, Heinz‐Joseph, Lee, Fa‐Chyi, Haller, Daniel G., Singh, Deepti, Benson, Al B., Strumberg, Dirk, Yanagihara, Ronald, Yao, James C., Phan, Alexandra T., Ajani, Jaffer A.

Volltext

A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers von Bauman, Julie, Shaheen, Monte, Verschraegen, Claire F, Belinsky, Steven A, Houman Fekrazad, M, Lee, Fa-Chyi, Rabinowitz, Ian, Ravindranathan, Meera, Jones, Dennie V

Volltext

Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide von Lee, Fa‐Chyi, Merchant, Shakil H.

Volltext

BRCA -Mutated Pancreatic Cancer: From Discovery to Novel Treatment Paradigms von Devico Marciano, Naomie, Kroening, Gianna, Dayyani, Farshid, Zell, Jason A, Lee, Fa-Chyi, Cho, May, Valerin, Jennifer Goldstein

Volltext

Near‐total resolution of multicentric Castleman disease by prolonged treatment with thalidomide von Starkey, Cindi R., Joste, Nancy E., Lee, Fa‐Chyi

Volltext

Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer von Shah, Manish A., Wainberg, Zev A., Catenacci, Daniel V. T., Hochster, Howard S., Ford, James, Kunz, Pamela, Lee, Fa-Chyi, Kallender, Howard, Cecchi, Fabiola, Rabe, Daniel C., Keer, Harold, Martin, Anne-Marie, Liu, Yuan, Gagnon, Robert, Bonate, Peter, Liu, Li, Gilmer, Tona, Bottaro, Donald P.

Volltext

Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer von Shah, Manish A, Wainberg, Zev A, Catenacci, Daniel V T, Hochster, Howard S, Ford, James, Kunz, Pamela, Lee, Fa-Chyi, Kallender, Howard, Cecchi, Fabiola, Rabe, Daniel C, Keer, Harold, Martin, Anne-Marie, Liu, Yuan, Gagnon, Robert, Bonate, Peter, Liu, Li, Gilmer, Tona, Bottaro, Donald P

Volltext

Financial Toxicity of Cancer Care: An Analysis of Financial Burden in Three Distinct Health Care Systems von Parikh, Divya A., Ragavan, Meera, Dutta, Ritika, Edwards, Jeffrey Garnet, Dickerson, James, Maitra, Debeshi, Aggarwal, Sangeeta, Lee, Fa-Chyi, Patel, Manali

Volltext

(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies von Picozzi, Vincent J, Ramanathan, Ramesh K, Lowery, Maeve A, Ocean, Allyson J, Mitchel, Edith P, O'Neil, Bert H, Guarino, Michael J, Conkling, Paul R, Cohen, Steven J, Bahary, Nathan, Frank, Richard C, Dragovich, Tomislav, Bridges, Benjamin B, Braiteh, Fadi S, Starodub, Alexander N, Lee, Fa-Chyi, Gribbin, Thomas E, Richards, Donald A, Lee, Marie, Korn, Ronald L, Pandit-Taskar, Neeta, Goldsmith, Stanley J, Intenzo, Charles M, Sheikh, Arif, Manzone, Timothy C, Horne, Heather, Sharkey, Robert M, Wegener, William A, O'Reilly, Eileen M, Goldenberg, David M, Von Hoff, Daniel D

Volltext

A Phase I Study of Sunitinib Plus Capecitabine in Patients With Advanced Solid Tumors von SWEENEY, Christopher J, CHIOREAN, E. Gabriela, BURRIS, Howard A, VERSCHRAEGEN, Claire F, FA CHYI LEE, JONES, Suzanne, ROYCE, Melanie, TYE, Lesley, LIAU, Katherine F, BELLO, Akintunde, CHAO, Richard

Volltext

Primary disseminated central neurocytoma: cytological and MRI evidence of tumor spread prior to surgery von Tran, Hoan, Medina-Flores, Rafael, Cerilli, Lisa A., Phelps, Jeremy, Lee, Fa-Chyi, Wong, Gene, Turner, Paul

Volltext

Phase II studies of antiangiogenic four drug regimens for the treatment of advanced renal cell carcinoma: FUNIL-retinoid and the FUNIL-thalidomide protocols von Pacheco, Alonso V., M.D, Rasila, Kanwaldeep, M.D, Lee, Sang-Joon, M.D, Rabinowitz, Ian, M.D, Elias, Laurence, M.D, Lee, Fa Chyi, M.D, Verschraegen, Claire F., M.D

Volltext